Found: 17
Select item for more details and to access through your institution.
CD56<sup>dim</sup> CD16<sup>−</sup> Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00014
- By:
- Publication type:
- Article
Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1075823
- By:
- Publication type:
- Article
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087705
- By:
- Publication type:
- Article
Mitochondrial Respiration - An Important Therapeutic Target in Melanoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0040690
- By:
- Publication type:
- Article
Poorer survival outcomes in patients with multiple versus single primary melanoma.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 11, p. 2098, doi. 10.1002/cncr.34169
- By:
- Publication type:
- Article
Indoor tanning exposure in association with multiple primary melanoma.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 4, p. 560, doi. 10.1002/cncr.33307
- By:
- Publication type:
- Article
Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A four-marker signature of TNF-RII, TGF-alpha, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.
- Published in:
- Journal of Translational Medicine, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1479-5876-12-19
- By:
- Publication type:
- Article
A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma.
- Published in:
- 2014
- By:
- Publication type:
- journal article
TIGIT and PD-1 impair tumor antigen-specific CD8⁺ T cells in melanoma patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
TIGIT and PD-1 impair tumor antigen-specific CD8<sup>+</sup> T cells in melanoma patients.
- Published in:
- Journal of Clinical Investigation, 2015, v. 125, n. 5, p. 2046, doi. 10.1172/JCI80445
- By:
- Publication type:
- Article
Multiple primary melanoma in association with other personal and familial cancers.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 3, p. 2474, doi. 10.1002/cam4.5088
- By:
- Publication type:
- Article
Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
- Published in:
- Lasers in Surgery & Medicine, 2021, v. 53, n. 4, p. 578, doi. 10.1002/lsm.23286
- By:
- Publication type:
- Article
Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1171978
- By:
- Publication type:
- Article
Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 20, p. 4973, doi. 10.3390/cancers14204973
- By:
- Publication type:
- Article
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients.
- Published in:
- PLoS ONE, 2015, v. 10, n. 7, p. 1, doi. 10.1371/journal.pone.0132745
- By:
- Publication type:
- Article